Our readers have spoken! See ten of the most popular diaTribe articles.

The VALyou program, designed to help people paying full-price for insulin not eligible for other patient assistance programs, now includes basal insulin Toujeo and rapid...

The study aims to enroll about 1,800 adults with type 2 diabetes at increased risk of heart disease

A huge milestone that makes Forxiga the first pill for people with type 1 diabetes in Europe

Google’s health arm Verily/Alcon has announced that its project to develop a glucose-sensing contact lens has been put on hold

Read about Kelly’s better quality of life on Loop, as well as the difficulties that ultimately ended her Looping experience; part 2 of a series on a hybrid-closed-loop...

When will we see a 670G with Bluetooth and remote monitoring? Also, the upcoming MiniMed 780G with automatic boluses, a seven-day wear infusion set, and better Medtronic...

MiniMed 780G to add automated correction boluses and Bluetooth, aims to launch by April 2020; Guardian Connect users can now use IQcast on Apple iPhones

We asked diabetes experts for their advice for people with diabetes. They emphasized being your own advocate, finding community, technology, and always asking questions

Contribute data to a new study on how overnight blood sugars affect sleep, activity, and mental state; four-week “virtual” trial recruiting people with type 1 on Dexcom...

The latest updates on time-in-range goals for people with all types of diabetes, and insights linking FreeStyle Libre scanning frequency to outcomes.

FlowSmart infusion set officially discontinued. On the plus side, BD plans to launch a tubeless type 2 diabetes insulin patch pump starting in late 2019.

One Drop’s Chrome becomes the first blood glucose meter to send data directly to Apple Watch without a nearby phone. Plus, new health features on the Series 4 Apple...

Diabeloop’s automated insulin delivery system includes the Kaleido insulin pump, an Android controller, and the Dexcom G6 CGM; it is the second hybrid closed loop...

From clinical expertise and personal experience as a type 1, Dr. Sherr shares valuable (and exciting) perspectives on diabetes treatments.

DIY Loop virtual study requires no in-person visits and seeks 300-1,000 Loop users, especially those new to Looping. Data will support eventual FDA submission of...

How Kerri Sparling navigates CGM sharing with friends and family and how it’s helped her feel less self-conscious about her numbers

The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!

The first trial, now recruiting 50 people, is an observational study of insulin requirements and glucose levels using the Dexcom G6 CGM in type 1 pregnancy.

Tubeless Omnipod will communicate directly with Tidepool Loop app. Insulet’s own Horizon hybrid closed loop expected to launch in second-half of 2020